glofitamab
roche
['glofitamab', 'lymsm']
. of , discussed extended follow-up data and landmark analyses from a phase 2 study of glofitamab monotherapy in patients with r/r lbcl. check back on our website for more #asco23 highlights: #lymsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.